FiercePharma· @FiercePharma · X·· 2 小时前精选AI 评分62
AI 导读
United Therapeutics与肺部疾病竞争对手Liquidia Technologies就Tyvaso专利侵权纠纷达成3.8亿美元和解，有分析师称这是United Therapeutics的一次明确胜利。相关报道链接为https://www.fiercepharma.com/pharma/united-lands-clearcut-win-liquidia-agrees-380m-settlement-tyvaso-patent-infringement-saga。
推荐理由
原文点出United Therapeutics与Liquidia的专利纠纷以3.8亿美元和解收场，读者可据此了解Tyvaso专利战的结局。
正文
United Therapeutics has clinched what one analyst calls a “clearcut win” over lung disease rival Liquidia Technologies. https://www.fiercepharma.com/pharma/united-lands-clearcut-win-liquidia-agrees-380m-settlement-tyvaso-patent-infringement-saga
来源：FiercePharma · x.com